← Leaderboards
Sun Yang
University Of California-Irvine
$1,386,951
Attributed
$1,594,701
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,594,701 · 3
By mechanism
R01$610,415 · 1
K08$568,786 · 1
R15$415,500 · 1
Top collaborators
- Keykavous Parang1 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Anand K Ganesan$12,565,599
- Roberto Tinoco$4,569,885
- Mei Kong$7,199,338
- Anshu Agrawal$3,499,313
- Abraham P Lee$2,915,919
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadTumor GrowthTumorMalignant NeoplasmsExhibitsIn VitroIn VivoStructureDesignScreeningPropertyEvaluationReactive Oxygen SpeciesResistanceProteinsSignal TransductionNuclearChemotherapyMolecularMonitorMouse ModelNeoplasm MetastasisOverexpressionMediating
Grant awards (7)
Development of small molecule selective inhibitors of neuronal nitric oxide synthase (nNOS) for melanoma treatment$610,415
R01 · FY2025 · CA · contact PI
Peptide-Doxorubicin Conjugates for Mitigating Cardiotoxicity and Overcoming Drug Resistance in Cancer$415,500
R15 · FY2025 · CA
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors$112,331
K08 · FY2018 · CA · contact PI
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors$113,074
K08 · FY2017 · CA · contact PI
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors$113,788
K08 · FY2016 · CA · contact PI
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors$114,468
K08 · FY2015 · CA · contact PI
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors$115,125
K08 · FY2014 · CA · contact PI